Nitrosamine (and/or Irbesartan) Induced Large Plaque Parapsoriasis and Urothelial Carcinoma: First Report in the Medical Literature!
https://symbiosisonlinepublishing.com/ dermatology/dermatology142.pdf
https://symbiosisonlinepublishing.com/ dermatology/dermatology142.pdf
https://symbiosisonlinepublishing.com/ dermatology/dermatology141.pdf
10-13 November 2021, Virtual Congress https://icd2021.com.au/industry-supporters/ Силна подкрепа от БДДХ/ Българско дружество по дерматологична хирургия за ХIII интернационален конгрес по дерматология , 10-13 ноември/ 2021, Мелбърн, Австралия
The complete interview for actualno.com: https://www.actualno.com/ healthy/news_1622185.html
The complete interview for actualno.com: https://www.actualno.com/ healthy/news_1616664.html The European Medicines Agency (EMA) has determined the minimum amounts of nitrosamines that may be part of the medicines for blood products known as ‘sartans’ (angiotensin receptor blockers). This is clear from an official announcement of the EMA. According to the report, it will now monitor the amount of nitrosamines not only in the active ingredient of the drug, but also in the … Read More
Visit: https://www.gmp-compliance.org/gmp-news/sartan-medicinal-products-emas-assesment-report-defines-nitrosamine-limits-and-reporting-deadlines
Click on the pictures for more information.
Visit: https://icd2021.com.au/
The complete interview for actualno.com: https://www.actualno.com/interview/ news_1603491.html